Caffeine impact on neonatal morbidities

References

• Aranda JV, Gorman W, Bergsteinsson H, Gunn T. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr 1977;90:467–472.
   PubMed Web of Science ®Google Scholar
• Jalal M, Abu-Shaweesh JM, Martin RJ. Neonatal apnea: what's new? Pediatric Pulmonology 2008;43:937–944.
   PubMedGoogle Scholar
• Di Fiore JM, Bloom JN, Orge F, Schutt A, Schluchter M, Cheruvu VK, Walsh M, Finer N, Martin RJ. A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr 2010;157:69–73.
   PubMed Web of Science ®Google Scholar
• Janvier A, Khairy M, Kokkotis A, Cormier C, Messmer D, Barrington KJ. Apnea is associated with neurodevelopmental impairment in very low birth weight infants. J Perinatol 2004;24:763–768.
   PubMedGoogle Scholar
• Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy 2000;20:644–652.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W. Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354:2112–2121.
   PubMed Web of Science ®Google Scholar
• Murphy JJ, Swanson T, Ansermino M, Milner R. The frequency of apneas in premature infants after inguinal hernia repair: do they need overnight monitoring in the intensive care unit? J Pediatr Surg 2008;43:865.
   PubMedGoogle Scholar
• Henderson-Smart DJ, Steer P. Prophylactic caffeine to prevent postoperative apnea following general anesthesia in preterm infants. Cochrane Database Syst Rev 2001;(4):CD000048.
   Google Scholar
• Yoder B, Thomson M, Coalson J. Lung function in immature baboons with respiratory distress syndrome receiving early caffeine therapy: a pilot study. Acta Paediatr 2005;94:92–98.
   PubMed Web of Science ®Google Scholar
• Davis PG, Schmidt B, Roberts RS, Doyle LW, Asztalos E, Haslam R, Sinha S, Tin W; Caffeine for Apnea of Prematurity Trial Group. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J Pediatr 2010;156:382–387.
   PubMed Web of Science ®Google Scholar
• Kassim Z, Greenough A, Rafferty GF. Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants. Eur J Pediatr 2009;168:1491–1495.
   PubMed Web of Science ®Google Scholar
• Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for extubation in preterm infants. Cochrane Database Syst Rev 2003;(1):CD000139.
   Google Scholar
• Steer P, Flenady V, Shearman A, Charles B, Gray PH, Henderson-Smart D, Bury G, Fraser S, Hegarty J, Rogers Y, et al High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2004;89:F499–F503.
   PubMed Web of Science ®Google Scholar
• Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006;117:1113–1121.
   PubMed Web of Science ®Google Scholar
• Clyman RI, Chorne N. Patent ductus arteriosus: evidence for and against treatment. J Pediatr 2007;150:216–219.
   PubMed Web of Science ®Google Scholar
• Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook AR, et al Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196:147.e1–147.e8.
   PubMed Web of Science ®Google Scholar
• Chiang MF, Arons RR, Flynn JT, Starren JB. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database. Ophthalmology 2004;111:1317–1325.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357:1893–1902.
   PubMed Web of Science ®Google Scholar
• Gunn TR, Metrakos K, Riley P, Willis D, Aranda JV. Sequelae of caffeine treatment in preterm infants with apnea. J Pediatr 1979;94:106–109.
   PubMedGoogle Scholar
• Ment LR, Scott DT, Ehrenkranz RA, Duncan CC. Early childhood developmental follow-up of infants with GMH/IVH: effect of methylxanthine therapy. Am J Perinatol 1985;2:223–227.
   PubMedGoogle Scholar
• Turmen T, Davis J, Aranda JV. Relationship of dose and plasma concentrations of caffeine and ventilation in neonatal apnea. Semin Perinatol 1981;5:326–331.
   PubMedGoogle Scholar
• Scanlon JE, Chin KC, Morgan ME, Durbin GM, Hale KA, Brown SS. Caffeine or theophylline for neonatal apnoea? Arch Dis Child 1992;67(4 Spec No):425–428.
   PubMedGoogle Scholar
• Steer PA, Flenady VJ, Shearman A, Lee TC, Tudehope DI, Charles BG. Periextubation caffeine in preterm neonates: a randomized dose response trial. J Paediatr Child Health 2003;39:511–515.
   PubMed Web of Science ®Google Scholar
• Anderson BJ, Gunn TR, Holford NH, Johnson R. Caffeine overdose in a premature infant: clinical course and pharmacokinetics. Anaesth Intensive Care 1999;27:307–311.
   PubMedGoogle Scholar
• Ergenekon E, Dalgic N, Aksoy E, Koc E, Atalay Y. Caffeine intoxication in a premature neonate. Paediatr Anaesth 2001;11:737–739.
   PubMedGoogle Scholar
• Natarajan G, Botica ML, Thomas R, Aranda JV. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics. 2007;119:936–940.
   PubMed Web of Science ®Google Scholar
• Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A, Neims AH. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 1979;94:663–668.
   PubMed Web of Science ®Google Scholar
• Charles BG, Townsend SR, Steer PA, Flenady VJ, Gray PH, Shearman A. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit 2008;30:709–716.
   PubMed Web of Science ®Google Scholar
• Aranda JV, Turmen T. Methylxanthines in apnea of prematurity. Clin Perinatol 1979;6:87–108.
   PubMed Web of Science ®Google Scholar
• Natarajan G, Lopes JM, Aranda JV. Pharmacologic treatment of neonatal apnea. In: Yaffe SJ, Aranda JV, editors. Neonatal and pediatric pharmacology, 4th ed. Philadelphia: Lippincott, Williams and Wilkins; 2010.
   Google Scholar